affiliate disclosure · we earn commission on some vendor links. audits, scores, and rankings are independent — vendors do not pay for placement. read more →
Is Peptide Partners legit?
Peptide Partners is operating and surfaces credible public signals (composite 50/100), but we have not placed a first-hand test order yet — this is a public-data audit. 32 Kovera vial reports at a 99.83% median purity, three Kovera fails its own ledger omits, and open FDA warning letter 735063. Public-data audit, 50/100. The signal table below shows what we verified and what is still open.
Signal table
What works, what does not
- +32 Kovera vial reports with an LC-MS identity line; median purity 99.83%
- +Publishes add-on panels most shops skip: 17 heavy-metal, 7 endotoxin and 4 sterility reports at Kovera
- +A 424-row public certificate ledger, searchable by the batch ID on the vial
- +Non-GLP vials 28-67% under our index median per mg
- +Finnrick's top retatrutide rating on 9 Oct 2026 (93% across 30 tests)
- −Open FDA warning letter 735063 (24 Aug 2026); all six named peptides still on sale on 9 Oct 2026
- −Three Kovera fails: Epithalon at 72.85% purity, Semax at 68.7% of label, a semaglutide sterility "Growth"
- −The shop's ledger shows passing reports for those three lots, not the fails
- −Four vials at 127-132% of label still marked PASS by Kovera
- −Wyoming LLC at a registered-agent address plus a Sarasota mailbox; we could not confirm the filing
- −Trustpilot profile removed; Finnrick rates it 66%, #332 of 457
What we mean by "legit"
We do not use "legit" as a single yes-or-no signal. A vendor is legit when four things hold: identifiable corporate operator, third-party or independently-mirrored COAs, shipping and payment infrastructure that consistently delivers, and a complaint history that surfaces real issues rather than vanishes them. Our composite score is the weighted average of those four — shipping, pricing, support, COA quality — and you can read the full rubric at /methodology.
For Peptide Partners the audit is "public-data tier" — we aggregate vendor disclosures, third-party COA mirrors, operating-history evidence, and complaint patterns. A first-hand test order is still pending and the page will be upgraded when that lands.
Verdict
32 Kovera vial reports at a 99.83% median purity, three Kovera fails its own ledger omits, and open FDA warning letter 735063. Public-data audit, 50/100.
Other audited vendors
Sources
- FDA warning letter 735063, Peptide Partners LLC, 24 August 2026 — FDA
- Peptide Partners independent certifications ledger — vendor
- Kovera Labs public verifier — third-party-lab
- Finnrick vendor page, Peptide Partners — Finnrick
- Wyoming Secretary of State commercial registered agent roster — Wyoming SOS
- vialaudit - FDA and Lilly peptide letters, August 2026 — vialaudit